Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
- Status
- COMPLETED
- Phase
- PHASE4
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE4
FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
- Status
- COMPLETED
- Phase
- PHASE2
Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
- Status
- COMPLETED
- Phase
- NA
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Letrozole in Preventing Breast Cancer in Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3